Tag: Tumor immune evasion mechanisms

A new review explains why IDO1 inhibitors often fail, revealing that tumors and tissues compensate by rerouting tryptophan metabolism through ...

A new computational platform reveals how collagen architecture and myeloid cells cooperate to trap therapeutic T cells in pancreatic tumors, ...

In a discovery that could reshape how scientists think about cancer immunotherapy, researchers in Japan have uncovered the hidden mechanism ...

A Blood Test Could Reveal How Oral Tumors Hide From the Immune System Oral squamous cell carcinoma, the most common ...

A molecule released by gut bacteria could help determine whether cancer patients respond to one of modern oncology’s most powerful ...

Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews ...

A previously unrecognized population of cancer-associated fibroblasts appears to act as a spatial organizer for immune suppression in lung cancer, ...

Neoadjuvant chemoimmunotherapy is changing the way doctors approach head and neck squamous cell carcinoma, a group of cancers that arise ...

Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...

Liver metastases are among the most difficult complications of advanced cancer. Unlike many other organs, the liver is continuously exposed ...